Advance in radiotherapy can be achieved by obtaining a greater tumour control and by reducing the morbidity of treatment, both early and late. The factors influencing both means of benefiting the cancer patient are considered.
No takes yet. Share an insight, caveat, or question.
S Dische (1992) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: